Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial

BACKGROUND: Very late (aged ≥60 years) onset schizophrenia-like psychosis occurs frequently but no placebo-controlled, randomised trials have assessed the efficacy and risks of antipsychotic treatment. We investigated whether low-dose amisulpride (100 mg daily) is superior to placebo in reducing psy...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Robert, Cort, Elizabeth, Bradley, Rosie, Harper, Emma, Kelly, Linda, Bentham, Peter, Ritchie, Craig, Reeves, Suzanne, Fawzi, Waleed, Livingston, Gill, Sommerlad, Andrew, Oomman, Sabu, Nazir, Ejaz, Nilforooshan, Ramin, Barber, Robert, Fox, Chris, Macharouthu, Ajay Verma, Ramachandra, Pranathi, Pattan, Vivek, Sykes, John, Curran, Val, Katona, Cornelius, Dening, Tom, Knapp, Martin, Gray, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015223/
https://www.ncbi.nlm.nih.gov/pubmed/29880238
http://dx.doi.org/10.1016/S2215-0366(18)30141-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015223/
https://www.ncbi.nlm.nih.gov/pubmed/29880238
http://dx.doi.org/10.1016/S2215-0366(18)30141-X

Ejemplares similares